Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Spinal Cord Injury WP2431,9.850749582559887e-07,4.625751229284283,63.97667487024299,"['C1QB', 'ANXA1', 'IL1R1', 'GADD45A', 'BDNF', 'PLA2G5', 'TACR1', 'FOS', 'RHOC', 'ICAM1', 'GFAP', 'LGALS3', 'ZFP36', 'COL4A1', 'CCL2', 'SLIT3', 'SOX9', 'VIM']",0.0004314628317161231,0,0,18
2,Nuclear Receptors Meta-Pathway WP2882,2.0183999017250064e-06,2.794286784547403,36.64205679903664,"['GSTP1', 'SLC2A1', 'IRS2', 'DBI', 'SLC2A4', 'SLC5A3', 'CYP3A7', 'DNAJB1', 'SRPX2', 'FTH1', 'PRDX1', 'PDK4', 'HMOX1', 'CCL2', 'HES1', 'JUNB', 'SREBF1', 'NQO1', 'HSP90AA1', 'GADD45B', 'GPX3', 'PTGES3', 'HGF', 'NRG1', 'SLC39A14', 'SOD3', 'SPINK13', 'ANGPTL4', 'GCLM', 'EPHA2', 'HSPA1A', 'FKBP5']",0.0004420295784777764,0,0,32
3,NRF2 pathway WP2884,2.1250882256288247e-05,3.558309174226129,38.28424745390568,"['NQO1', 'HSP90AA1', 'GPX3', 'HGF', 'GSTP1', 'SLC2A1', 'NRG1', 'SLC2A4', 'SLC5A3', 'SLC39A14', 'SOD3', 'DNAJB1', 'FTH1', 'PRDX1', 'HMOX1', 'GCLM', 'EPHA2', 'HSPA1A']",0.0031026288094180843,0,0,18
4,Oxidative Stress WP408,6.202193124169648e-05,7.748840744963892,75.07094353077579,"['NQO1', 'GPX3', 'HMOX1', 'MT1X', 'FOS', 'SOD2', 'JUNB', 'SOD3']",0.006791401470965764,0,0,8
5,IL1 and megakaryocytes in obesity WP2865,8.468911679351022e-05,12.43295953193564,116.57793667600544,"['IL1R1', 'IL18', 'CCL2', 'TIMP1', 'MYD88', 'ICAM1']",0.007418766631111495,0,0,6
6,Vitamin D Receptor Pathway WP2877,0.00038239966647832165,3.2386784028575075,25.485303660261213,"['CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'SLC2A4', 'ATP2C2', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",0.02397761092764343,0,0,14
7,Zinc homeostasis WP3529,0.0003832038276107398,5.5322799587337785,43.522133990839656,"['MT2A', 'MT1A', 'MT1M', 'MT1F', 'MT1G', 'MT1X', 'MT3', 'SLC39A14']",0.02397761092764343,0,0,8
8,Lung fibrosis WP3624,0.0008072810832732236,5.6424322956213615,40.184492368706316,"['MT2A', 'CEBPB', 'EGF', 'HGF', 'HMOX1', 'CCL2', 'TIMP1']",0.04155220530394764,0,0,7
9,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0010151379828970816,3.726886446886447,25.688424747079797,"['SOCS3', 'NQO1', 'CDKN1A', 'HSPA5', 'HSPB1', 'NRG1', 'APOE', 'VIM', 'YBX3', 'CARD14']",0.04155220530394764,0,0,10
10,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0010151379828970816,3.726886446886447,25.688424747079797,"['SREBF1', 'CDKN1A', 'CEBPB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'HES5']",0.04155220530394764,0,0,10
11,Hematopoietic Stem Cell Differentiation WP2849,0.0010435485350306485,5.345042560844023,36.69440306011758,"['HES6', 'SPI1', 'TRIM29', 'PIM1', 'NFATC2', 'FOS', 'RUNX1']",0.04155220530394764,0,0,7
12,Transcriptional cascade regulating adipogenesis WP4211,0.0017028284282219826,11.579568671963678,73.82513048907698,"['SREBF1', 'CEBPB', 'CEBPD', 'KLF2']",0.062153237630102366,0,0,4
13,IL-18 signaling pathway WP4754,0.0018631084309440134,2.087504143188598,13.121026051836862,"['CEBPB', 'TICAM2', 'CD81', 'RGS16', 'IL18', 'HSPB1', 'TNFRSF11B', 'FOS', 'TACR1', 'KLF2', 'ICAM1', 'VEGFA', 'TNFRSF1A', 'ACTA2', 'CCNA2', 'SOCS3', 'NFKBIZ', 'HMOX1', 'CCL2', 'TIMP1', 'PTPN7', 'MYD88', 'ARF6']",0.0627724225194983,0,0,23
14,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0026930467645212394,9.648883844116535,57.093237879864446,"['CDKN1A', 'GALNT3', 'FAM20C', 'FGFR3']",0.07789770826717148,0,0,4
15,Complement and Coagulation Cascades WP558,0.002845578384188912,5.115438666934351,29.986644855984064,"['C1QB', 'SERPIND1', 'C1R', 'CFI', 'SERPING1', 'CLU']",0.07789770826717148,0,0,6
16,Prostaglandin Synthesis and Regulation WP98,0.002845578384188912,5.115438666934351,29.986644855984064,"['HSD11B1', 'ANXA1', 'ANXA2', 'S100A6', 'SOX9', 'S100A10']",0.07789770826717148,0,0,6
17,The influence of laminopathies on Wnt signaling WP4844,0.003141011501455173,4.229831055429005,24.37740631499503,"['SREBF1', 'CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'SLC2A4', 'HES5']",0.08092723750808034,0,0,7
18,Globo Sphingolipid Metabolism WP1424,0.003646276038839578,6.034564393939394,33.87833957087418,"['ST6GAL1', 'ST6GAL2', 'FUT2', 'ST6GALNAC3', 'A4GALT']",0.08872605027842974,0,0,5
19,Vitamin B12 metabolism WP1533,0.004467430808330634,4.576252918986887,24.76183820137933,"['SERPINA3', 'CCL2', 'APOE', 'SOD2', 'SOD3', 'ICAM1']",0.10298603652888515,0,0,6
20,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.004782634783300724,5.56993006993007,29.758820046813454,"['NQO1', 'GSTP1', 'HMOX1', 'FOS', 'GCLM']",0.10473970175428585,0,0,5
21,Vitamin A and carotenoid metabolism WP716,0.005494598376713312,4.347098976109215,22.622258655874766,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RLBP1', 'RPE65']",0.1088907701722974,0,0,6
22,Fatty acid transporters WP5061,0.0057180084793672144,7.235527809307605,37.36524024847289,"['FABP5', 'FABP7', 'DBI', 'ACSBG2']",0.1088907701722974,0,0,4
23,Galanin receptor pathway WP4970,0.0057180084793672144,7.235527809307605,37.36524024847289,"['CDKN1A', 'FOS', 'SLC2A4', 'VEGFA']",0.1088907701722974,0,0,4
24,Ovarian infertility WP34,0.006149298029999017,5.171672077922078,26.33114092091861,"['CEBPB', 'MSH5', 'ZP3', 'INHA', 'SYNE2']",0.11222468904748206,0,0,5
25,Adipogenesis WP236,0.006854717343618284,2.3623996559633027,11.77140800241365,"['SREBF1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'GADD45A', 'EBF1', 'IRS2', 'SLC2A4', 'SOCS3', 'KLF6', 'NAMPT', 'PNPLA3']",0.12009464786019233,0,0,13
26,Sleep regulation WP3591,0.0077685826379195145,4.826515151515151,23.44560601142723,"['CST3', 'OXTR', 'IL18', 'GHRL', 'FOS']",0.12264612718293694,0,0,5
27,Gene regulatory network modelling somitogenesis  WP2854,0.007815579415468964,10.84438775510204,52.61302394358694,"['LFNG', 'HES1', 'TBX6']",0.12264612718293694,0,0,3
28,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.007840391692059896,6.4310757977046284,31.180855468603767,"['CD63', 'EGF', 'CD81', 'HSPB1']",0.12264612718293694,0,0,4
29,Differentiation Pathway WP2848,0.009661929927378587,4.524502840909091,20.991710839984183,"['NT5E', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.14592845890316625,0,0,5
30,Phytochemical activity on NRF2 transcriptional activation WP3,0.01042114014848526,5.787514188422247,26.413744979973476,"['NQO1', 'CEBPB', 'HMOX1', 'GCLM']",0.1468251159138332,0,0,4
31,Complement system WP2806,0.011709573247239308,3.170380125284738,14.099785438814163,"['C1R', 'CFI', 'F11', 'SERPING1', 'ADM', 'CD59', 'ICAM1']",0.1468251159138332,0,0,7
32,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.011849668857919288,4.258021390374331,18.88626378305162,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.1468251159138332,0,0,5
33,Type II interferon signaling (IFNG) WP619,0.011849668857919288,4.258021390374331,18.88626378305162,"['SOCS3', 'SPI1', 'TAP1', 'GBP1', 'ICAM1']",0.1468251159138332,0,0,5
34,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.011906694472274056,8.67482993197279,38.435174069646806,"['SMAD1', 'SST', 'SMAD9']",0.1468251159138332,0,0,3
35,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.011906694472274056,8.67482993197279,38.435174069646806,"['EGF', 'TIMP1', 'VIM']",0.1468251159138332,0,0,3
36,EV release from cardiac cells and their functional effects WP3297,0.012067817746342456,28.892412231030576,127.62394064253083,"['RGS16', 'KLF2']",0.1468251159138332,0,0,2
37,Selenium Micronutrient Network WP15,0.012784970031972818,2.8291570486970548,12.333667756728346,"['SERPINA3', 'SELENOM', 'GPX3', 'PRDX1', 'CCL2', 'SOD2', 'SOD3', 'ICAM1']",0.15134640200011068,0,0,8
38,Aryl Hydrocarbon Receptor Pathway WP2873,0.01718287320882589,3.8092105263157894,15.480030237614193,"['NQO1', 'HSP90AA1', 'PTGES3', 'HES1', 'JUNB']",0.19297688372989072,0,0,5
39,White fat cell differentiation WP4149,0.01718287320882589,3.8092105263157894,15.480030237614193,"['SREBF1', 'CEBPB', 'CEBPD', 'EBF1', 'KLF2']",0.19297688372989072,0,0,5
40,Aryl Hydrocarbon Receptor Netpath WP2586,0.017977464776878744,3.218303627859942,12.933191661941141,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.19685323930682222,0,0,6
41,Transcription factor regulation in adipogenesis WP3599,0.021220570677954475,4.450886230681918,17.148304380386993,"['CEBPB', 'CEBPD', 'IRS2', 'SLC2A4']",0.22669780382790392,0,0,4
42,Eicosanoid Synthesis WP167,0.023143910906440628,6.19533527696793,23.331778620409743,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.24135792802430941,0,0,3
43,Genotoxicity pathway WP4286,0.024719573335385932,2.66853494784798,9.874006022953024,"['ACTA2', 'ITPKC', 'PLK3', 'CDKN1A', 'CEBPD', 'GADD45A', 'AEN']",0.2517947237418381,0,0,7
44,Folate Metabolism WP176,0.030333950087089667,2.8021578773532974,9.794908474445014,"['SERPINA3', 'GPX3', 'CCL2', 'SOD2', 'SOD3', 'ICAM1']",0.29194382655393647,0,0,6
45,Copper homeostasis WP3286,0.030660767172331228,2.5347095671981776,8.832883366327811,"['MT2A', 'MT1A', 'MT1F', 'MT1G', 'MT1X', 'SOD3', 'MT3']",0.29194382655393647,0,0,7
46,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.030660767172331228,2.5347095671981776,8.832883366327811,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'FOS', 'MYD88']",0.29194382655393647,0,0,7
47,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.03411623263543581,2.714377133105802,9.169117036025998,"['CCNA2', 'CDKN1A', 'HSP90AA1', 'FOS', 'JUNB', 'TNFRSF1A']",0.31793425307065715,0,0,6
48,Striated Muscle Contraction Pathway WP383,0.037043567009434585,3.615493757094211,11.915440224616917,"['ACTA2', 'TNNT1', 'VIM', 'TTN']",0.3380225489610906,0,0,4
49,Endochondral Ossification with Skeletal Dysplasias WP4808,0.042561264719075564,2.554306364183899,8.063461708141162,"['ADAMTS1', 'COL10A1', 'SOX9', 'SLC38A2', 'FGFR3', 'VEGFA']",0.37283667893910194,0,0,6
50,Endochondral Ossification WP474,0.042561264719075564,2.554306364183899,8.063461708141162,"['ADAMTS1', 'COL10A1', 'SOX9', 'SLC38A2', 'FGFR3', 'VEGFA']",0.37283667893910194,0,0,6
51,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.043486313605008146,3.4025505775522467,10.66804751736296,"['TICAM2', 'IRAK2', 'CCL2', 'MYD88']",0.3734706933135994,0,0,4
52,Type 2 papillary renal cell carcinoma WP4241,0.0473778569075772,2.782124125874126,8.484366605849697,"['CDKN1A', 'EGLN3', 'SLC2A1', 'COL21A1', 'VEGFA']",0.394359029875729,0,0,5
53,Hypertrophy Model WP516,0.04771924334112703,4.335714285714285,13.191066190187577,"['IL1R1', 'IL18', 'VEGFA']",0.394359029875729,0,0,3
54,IL-1 signaling pathway WP195,0.04949295043867124,2.252189319159706,6.769912257863898,"['IL1R1', 'IRAK2', 'HSPB2', 'CCL2', 'TAB2', 'IL1RAP', 'MYD88']",0.4014428202247778,0,0,7
55,NRF2-ARE regulation WP4357,0.050516687404930385,3.213267751292723,9.593055200304564,"['NQO1', 'CEBPB', 'HMOX1', 'GCLM']",0.4022965287883547,0,0,4
56,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.05293979504934761,7.2214043035107585,21.220818350983855,"['SOCS3', 'CHI3L1']",0.4068005303791974,0,0,2
57,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.05293979504934761,7.2214043035107585,21.220818350983855,"['LFNG', 'TBX6']",0.4068005303791974,0,0,2
58,Cori Cycle WP1946,0.057891466224937134,3.941249226963513,11.229349335231367,"['SLC2A1', 'GPT', 'SLC2A4']",0.42435311952542565,0,0,3
59,Differentiation of white and brown adipocyte WP2895,0.057891466224937134,3.941249226963513,11.229349335231367,"['SMAD1', 'CEBPB', 'SMAD9']",0.42435311952542565,0,0,3
60,miRNAs involvement in the immune response in sepsis WP4329,0.05813056431855146,3.0439094330605174,8.660116201959056,"['IRF7', 'TAB2', 'MYD88', 'ICAM1']",0.42435311952542565,0,0,4
61,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.06628582153158541,2.493730407523511,6.767433854679709,"['IFITM3', 'BST2', 'IFITM2', 'FOS', 'JUNB']",0.4506290452905128,0,0,5
62,TYROBP causal network in microglia WP3945,0.06632011033837583,2.8914869466515323,7.84536195780206,"['IGSF6', 'IL18', 'PPP1R18', 'IL13RA1']",0.4506290452905128,0,0,4
63,Oncostatin M Signaling Pathway WP2374,0.06890471454333444,2.0676863000325416,5.5311242838691985,"['SOCS3', 'CEBPB', 'CCL2', 'FOS', 'OSMR', 'JUNB', 'VEGFA']",0.4506290452905128,0,0,7
64,NAD+ metabolism WP3644,0.06899099613726799,3.612528344671202,9.659103413504749,"['NT5E', 'NAMPT', 'CD38']",0.4506290452905128,0,0,3
65,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.06899099613726799,3.612528344671202,9.659103413504749,"['ICAM1', 'VEGFA', 'TNFRSF1A']",0.4506290452905128,0,0,3
66,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.07098950713480681,5.776670441676104,15.280582669320225,"['SPI1', 'APOE']",0.4506290452905128,0,0,2
67,Farnesoid X receptor pathway WP2879,0.07098950713480681,5.776670441676104,15.280582669320225,"['IRS2', 'FKBP5']",0.4506290452905128,0,0,2
68,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.07098950713480681,5.776670441676104,15.280582669320225,"['HES1', 'VEGFA']",0.4506290452905128,0,0,2
69,Platelet-mediated interactions with vascular and circulating cells WP4462,0.07098950713480681,5.776670441676104,15.280582669320225,"['CCL2', 'ICAM1']",0.4506290452905128,0,0,2
70,Ferroptosis WP4313,0.07339721972962712,2.410416666666667,6.295693104879755,"['FTH1', 'HMOX1', 'GCLM', 'CP', 'SLC39A14']",0.45750481459218484,0,0,5
71,Signal transduction through IL1R WP4496,0.0750740932019778,2.7535808875195937,7.129791214824537,"['IRAK2', 'IL1R1', 'IL1RAP', 'MYD88']",0.45750481459218484,0,0,4
72,IL-4 signaling pathway WP395,0.075206270891866,2.170136518771331,5.615273081645895,"['SOCS3', 'CEBPB', 'NFIL3', 'FLNA', 'IRS2', 'FOS']",0.45750481459218484,0,0,6
73,Osteoblast differentiation WP4787,0.0784484065500456,1.810074200913242,4.607207406758398,"['HES6', 'SMAD1', 'WNT7B', 'FZD9', 'SMAD9', 'WNT7A', 'PRKCQ', 'SOX9', 'FGFR3']",0.47069043930027366,0,0,9
74,Pregnane X receptor pathway WP2876,0.08096921359841915,3.3343799058084773,8.381585006833523,"['HSP90AA1', 'SRPX2', 'CYP3A7']",0.4792502102176701,0,0,3
75,Oxysterols derived from cholesterol WP4545,0.08437820071257741,2.6282117428541945,6.498112126264145,"['CYP39A1', 'HSD3B7', 'DHCR7', 'ACOT6']",0.4927686921614521,0,0,4
76,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.08870252071283909,1.4434421967764168,3.4966910471938815,"['SREBF1', 'PFKFB1', 'CDKN1A', 'HSP90AA1', 'LAMA2', 'EGF', 'HGF', 'TNC', 'SLC2A1', 'IRS2', 'SLC2A4', 'OSMR', 'VEGFA', 'THBS3', 'EFNA1', 'COL4A1', 'IL3RA', 'FGFR3', 'EPHA2']",0.5092244157187664,0,0,19
77,Complement Activation WP545,0.09068380005950635,4.813514533786335,11.554247400177415,"['C1QB', 'C1R']",0.5092244157187664,0,0,2
78,Inflammatory Response Pathway WP453,0.09068380005950635,4.813514533786335,11.554247400177415,"['THBS3', 'TNFRSF1A']",0.5092244157187664,0,0,2
79,Male infertility WP4673,0.09361095385712091,1.7372602739726026,4.114888364045651,"['NANOS1', 'NQO1', 'BHMT', 'MSH5', 'XRCC3', 'PON1', 'SOD2', 'CLU', 'SOD3']",0.5190075669546704,0,0,9
80,Glucocorticoid Receptor Pathway WP2880,0.09567253824658213,2.018255417096595,4.736490207325922,"['HSP90AA1', 'GADD45B', 'PTGES3', 'CCL2', 'SPINK13', 'ANGPTL4']",0.5238071469000372,0,0,6
81,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.10033897181540387,1.6092041698449022,3.699884008671748,"['RYR2', 'CEBPB', 'BDNF', 'SST', 'CHRNA7', 'PAH', 'HES1', 'TACR1', 'HES5', 'GCK', 'VEGFA']",0.542573699446258,0,0,11
82,Cytoplasmic Ribosomal Proteins WP477,0.1046054280006212,1.691869774061555,3.819497249268434,"['RPS25', 'RPL32', 'RPL26', 'FAU', 'RPS27A', 'RPL9', 'RPS21', 'RPS13', 'RPS12']",0.5587460666374645,0,0,9
83,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.11173386377073552,4.125546028150785,9.041692932924198,"['ANXA2', 'APOE']",0.5826122896616923,0,0,2
84,Serotonin and anxiety-related events WP3944,0.11173386377073552,4.125546028150785,9.041692932924198,"['FOS', 'GRIN2D']",0.5826122896616923,0,0,2
85,Neural Crest Differentiation WP2064,0.11955915314950664,1.7763657435159652,3.7729014065339452,"['SMAD1', 'HES1', 'SOX9', 'TBX6', 'FGFR3', 'HES5', 'GFAP']",0.616081283288046,0,0,7
86,Peptide GPCRs WP24,0.12162266418694127,2.708545918367347,5.706451061797158,"['OXTR', 'GNRHR', 'TACR1']",0.6194270571381428,0,0,3
87,SCFA and skeletal muscle substrate metabolism WP4030,0.12554197108946344,14.429864253393665,29.94362985724629,['SLC2A4'],0.6307180581267883,0,0,1
88,Bladder cancer WP2828,0.12671960985195746,2.2231729677813674,4.592582762425012,"['CDKN1A', 'EGF', 'FGFR3', 'VEGFA']",0.6307180581267883,0,0,4
89,MAPK Signaling Pathway WP382,0.1313290715125993,1.3840612540775643,2.8097123160436785,"['PTPRR', 'IL1R1', 'GADD45A', 'BDNF', 'EGF', 'CACNA2D3', 'CACNA1A', 'HSPB1', 'FOS', 'TNFRSF1A', 'FLNA', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'HSPA1B', 'HSPA1A']",0.6463161047473988,0,0,17
90,Development and heterogeneity of the ILC family WP3893,0.13388136711359824,3.6095696489241225,7.258126949798549,"['NFIL3', 'IL18']",0.6500890962609831,0,0,2
91,7-oxo-C and 7beta-HC pathways WP5064,0.13654839464842566,2.549019607843137,5.075292243010323,"['HSD11B1', 'DHCR7', 'ACOT6']",0.6500890962609831,0,0,3
92,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.13654839464842566,2.549019607843137,5.075292243010323,"['NAMPT', 'SLC2A1', 'SLC2A4']",0.6500890962609831,0,0,3
93,Oxidative Damage WP3941,0.13847394837957366,2.140665069155421,4.232251258810817,"['C1QB', 'CDKN1A', 'C1R', 'GADD45A']",0.6521676278521856,0,0,4
94,Apoptosis Modulation and Signaling WP1772,0.14244347974147414,1.6871488230827638,3.2879324833120527,"['IL1R1', 'BAG3', 'TNFRSF11B', 'FOS', 'MYD88', 'TNFRSF1A', 'HSPA1A']",0.6544118147506777,0,0,7
95,Exercise-induced Circadian Regulation WP410,0.14394487728480734,1.9017643540669857,3.6862371050480762,"['CEBPB', 'RBPMS', 'PPP1R3C', 'GSTP1', 'TAB2']",0.6544118147506777,0,0,5
96,One-carbon metabolism and related pathways WP3940,0.14394487728480734,1.9017643540669857,3.6862371050480762,"['BHMT', 'GPX3', 'SOD2', 'GCLM', 'SOD3']",0.6544118147506777,0,0,5
97,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.15205874789277068,2.4072184429327286,4.533967853480953,"['CDKN1A', 'SOX9', 'FGFR3']",0.6544118147506777,0,0,3
98,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.15689572578824762,3.208254687303385,5.942245472037657,"['TNC', 'VEGFA']",0.6544118147506777,0,0,2
99,Glutathione metabolism WP100,0.15689572578824762,3.208254687303385,5.942245472037657,"['GPX3', 'GCLM']",0.6544118147506777,0,0,2
100,ID signaling pathway WP53,0.15689572578824762,3.208254687303385,5.942245472037657,"['SREBF1', 'PAX8']",0.6544118147506777,0,0,2
101,Kynurenine Pathway and links to Cellular Senescence WP5044,0.15689572578824762,3.208254687303385,5.942245472037657,"['CDKN1A', 'HAAO']",0.6544118147506777,0,0,2
102,Leptin Insulin Overlap WP3935,0.15689572578824762,3.208254687303385,5.942245472037657,"['SOCS3', 'IRS2']",0.6544118147506777,0,0,2
103,Matrix Metalloproteinases WP129,0.15689572578824762,3.208254687303385,5.942245472037657,"['MMP15', 'TIMP1']",0.6544118147506777,0,0,2
104,NOTCH1 regulation of endothelial cell calcification WP3413,0.15689572578824762,3.208254687303385,5.942245472037657,"['FGFR3', 'VEGFA']",0.6544118147506777,0,0,2
105,Tryptophan catabolism leading to NAD+ production WP4210,0.15689572578824762,3.208254687303385,5.942245472037657,"['HAAO', 'NAMPT']",0.6544118147506777,0,0,2
106,Glycolysis and Gluconeogenesis WP534,0.16320646350354492,1.9927198716192414,3.612281490537527,"['PGAM2', 'SLC2A1', 'SLC2A4', 'GCK']",0.6544118147506777,0,0,4
107,PPAR signaling pathway WP3942,0.1649753030716535,1.8063920454545455,3.255045297345546,"['FABP5', 'FABP7', 'DBI', 'ANGPTL4', 'ACSBG2']",0.6544118147506777,0,0,5
108,Heart Development WP1591,0.16809171022244285,2.280343716433942,4.066412794706409,"['SMAD1', 'NFATC2', 'VEGFA']",0.6544118147506777,0,0,3
109,TLR4 Signaling and Tolerance WP3851,0.16809171022244285,2.280343716433942,4.066412794706409,"['IRF7', 'TAB2', 'MYD88']",0.6544118147506777,0,0,3
110,Toll-like Receptor Signaling related to MyD88 WP3858,0.16809171022244285,2.280343716433942,4.066412794706409,"['TICAM2', 'IRF7', 'MYD88']",0.6544118147506777,0,0,3
111,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.17234937068768916,1.6677605670779732,2.9323093926252044,"['TUBB2B', 'TUBA1A', 'HSPA5', 'RNF19A', 'HSPA1B', 'HSPA1A']",0.6544118147506777,0,0,6
112,Cancer immunotherapy by PD-1 blockade WP4585,0.18057159603053868,2.887202718006795,4.941816800009835,"['NFATC2', 'PDCD1LG2']",0.6544118147506777,0,0,2
113,Computational Model of Aerobic Glycolysis WP4629,0.18057159603053868,2.887202718006795,4.941816800009835,"['PGAM2', 'SLC2A1']",0.6544118147506777,0,0,2
114,FOXA2 pathway WP5066,0.18057159603053868,2.887202718006795,4.941816800009835,"['SREBF1', 'IRS2']",0.6544118147506777,0,0,2
115,Overview of nanoparticle effects WP3287,0.18057159603053868,2.887202718006795,4.941816800009835,"['COL4A1', 'HMOX1']",0.6544118147506777,0,0,2
116,Endometrial cancer WP4155,0.18211698452966116,1.6361645952733594,2.786561782153299,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'FOS', 'FGFR3']",0.6544118147506777,0,0,6
117,Benzene metabolism WP3891,0.1822790899533851,7.214366515837104,12.280412314760406,['NQO1'],0.6544118147506777,0,0,1
118,COVID-19 adverse outcome pathway WP4891,0.1822790899533851,7.214366515837104,12.280412314760406,['CCL2'],0.6544118147506777,0,0,1
119,Drug Induction of Bile Acid Pathway WP2289,0.1822790899533851,7.214366515837104,12.280412314760406,['SLC51A'],0.6544118147506777,0,0,1
120,Hypothetical Craniofacial Development Pathway WP3655,0.1822790899533851,7.214366515837104,12.280412314760406,['ARHGAP29'],0.6544118147506777,0,0,1
121,Metabolism of alpha-linolenic acid WP4586,0.1822790899533851,7.214366515837104,12.280412314760406,['ALOX12'],0.6544118147506777,0,0,1
122,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.1822790899533851,7.214366515837104,12.280412314760406,['VEGFA'],0.6544118147506777,0,0,1
123,Cell migration and invasion through p75NTR WP4561,0.18458588651757507,2.166156462585034,3.6600255027447073,"['EFNA1', 'EFNB1', 'BDNF']",0.6573058397942917,0,0,3
124,MECP2 and Associated Rett Syndrome WP3584,0.19209838645356792,1.6057388446466945,2.649063819242222,"['CEBPD', 'BCL6', 'BDNF', 'SST', 'TAP1', 'FKBP5']",0.6785239253198706,0,0,6
125,ESC Pluripotency Pathways WP3931,0.1936426727511046,1.4827939069672251,2.4343631235729375,"['SMAD1', 'EGF', 'WNT7B', 'FZD9', 'SMAD9', 'WNT7A', 'FOS', 'FGFR3']",0.6785239253198706,0,0,8
126,RANKL/RANK signaling pathway WP2018,0.1986005181769369,1.679968287526427,2.71560140067681,"['SPI1', 'TNFRSF11B', 'TAB2', 'FOS', 'ICAM1']",0.6900808518323818,0,0,5
127,16p11.2 distal deletion syndrome WP4950,0.20148100085105455,2.062844185293165,3.304800548712646,"['PLN', 'CD81', 'NFATC2']",0.6900808518323818,0,0,3
128,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2047265759633642,2.6245238340368577,4.1627046732003326,"['RYR2', 'CD38']",0.6900808518323818,0,0,2
129,TP53 network WP1742,0.2047265759633642,2.6245238340368577,4.1627046732003326,"['CDKN1A', 'GADD45A']",0.6900808518323818,0,0,2
130,Breast cancer pathway WP4262,0.20481851766714526,1.3904395604395605,2.2047240311815144,"['CDKN1A', 'GADD45B', 'GADD45A', 'EGF', 'WNT7B', 'FZD9', 'WNT7A', 'HES1', 'FOS', 'HES5']",0.6900808518323818,0,0,10
131,Integrated breast cancer pathway WP1984,0.20829689365877405,1.3596980187369203,2.133081801923995,"['SMAD1', 'PLK3', 'ITPKC', 'ANXA1', 'RASGEF1A', 'GADD45A', 'XRCC3', 'FILIP1', 'FAU', 'FOSL2', 'VEGFA']",0.6944532135259894,0,0,11
132,TGF-beta Receptor Signaling WP560,0.2167793491931084,1.7506277301964022,2.6764914379888687,"['SMAD1', 'EGF', 'SMAD9', 'FOS']",0.6944532135259894,0,0,4
133,Metapathway biotransformation Phase I and II WP702,0.2282172677288751,1.4100175209277748,2.0832405033686094,"['CYP39A1', 'HS3ST3B1', 'CHST6', 'GPX3', 'GSTP1', 'CYP4F3', 'HS3ST4', 'CYP3A7']",0.6944532135259894,0,0,8
134,Cysteine and methionine catabolism WP4504,0.22919909869393537,2.40562476406191,3.543880344916907,"['BHMT', 'SQOR']",0.6944532135259894,0,0,2
135,Imatinib and Chronic Myeloid Leukemia WP3640,0.22919909869393537,2.40562476406191,3.543880344916907,"['GADD45A', 'PIM1']",0.6944532135259894,0,0,2
136,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.22919909869393537,2.40562476406191,3.543880344916907,"['TNC', 'VIM']",0.6944532135259894,0,0,2
137,Type II diabetes mellitus WP1584,0.22919909869393537,2.40562476406191,3.543880344916907,"['CACNA1A', 'SLC2A4']",0.6944532135259894,0,0,2
138,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.2308597690884165,1.6990051412165321,2.4906477740595188,"['CD160', 'CXCL17', 'IRF7', 'CCL2']",0.6944532135259894,0,0,4
139,Wnt signaling pathway and pluripotency WP399,0.23160719863388965,1.4449886104783598,2.1136028329408885,"['WNT7B', 'ESRRB', 'FZD9', 'WNT7A', 'PRKCQ', 'ZBTB33', 'CD44']",0.6944532135259894,0,0,7
140,p53 transcriptional gene network WP4963,0.23431744355113454,1.570034584980237,2.2782434094789576,"['CDKN1A', 'GADD45A', 'SLC2A1', 'CCL2', 'ICAM1']",0.6944532135259894,0,0,5
141,Cells and molecules involved in local acute inflammatory response  WP4493,0.23533884835533586,4.80920060331825,6.957609477047262,['ICAM1'],0.6944532135259894,0,0,1
142,Composition of Lipid Particles WP3601,0.23533884835533586,4.80920060331825,6.957609477047262,['APOE'],0.6944532135259894,0,0,1
143,GABA metabolism (aka GHB) WP4157,0.23533884835533586,4.80920060331825,6.957609477047262,['ADHFE1'],0.6944532135259894,0,0,1
144,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.23533884835533586,4.80920060331825,6.957609477047262,['CDKN1A'],0.6944532135259894,0,0,1
145,Small Ligand GPCRs WP247,0.23533884835533586,4.80920060331825,6.957609477047262,['S1PR3'],0.6944532135259894,0,0,1
146,Somatic sex determination WP4814,0.23533884835533586,4.80920060331825,6.957609477047262,['SOX9'],0.6944532135259894,0,0,1
147,The alternative pathway of fetal androgen synthesis WP4524,0.23533884835533586,4.80920060331825,6.957609477047262,['HSD17B6'],0.6944532135259894,0,0,1
148,Oxidation by Cytochrome P450 WP43,0.2362409333684302,1.8831706595681752,2.7172327648580787,"['CYP39A1', 'CYP4F3', 'CYP3A7']",0.6944532135259894,0,0,3
149,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2362409333684302,1.8831706595681752,2.7172327648580787,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.6944532135259894,0,0,3
150,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.24660627240476593,1.5365087040618957,2.151054187143199,"['RYR2', 'LAMA2', 'ACTN1', 'CACNA2D3', 'DSC2']",0.7041103117938867,0,0,5
151,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.24660627240476593,1.5365087040618957,2.151054187143199,"['IFI27L2', 'PLCE1', 'CCL2', 'PRKCQ', 'TNFRSF1A']",0.7041103117938867,0,0,5
152,Notch Signaling Pathway Netpath WP61,0.24660627240476593,1.5365087040618957,2.151054187143199,"['PSENEN', 'HES6', 'CDKN1A', 'HES1', 'HES5']",0.7041103117938867,0,0,5
153,Cholesterol Biosynthesis Pathway WP197,0.2538465014403905,2.2204024740831083,3.044228455927242,"['MSMO1', 'DHCR7']",0.7041103117938867,0,0,2
154,ERK Pathway in Huntington's Disease WP3853,0.2538465014403905,2.2204024740831083,3.044228455927242,"['EGF', 'BDNF']",0.7041103117938867,0,0,2
155,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2538465014403905,2.2204024740831083,3.044228455927242,"['ACTN1', 'PRKCQ']",0.7041103117938867,0,0,2
156,Monoamine GPCRs WP58,0.2538465014403905,2.2204024740831083,3.044228455927242,"['HTR1E', 'HTR2B']",0.7041103117938867,0,0,2
157,IL17 signaling pathway WP2112,0.253994130738434,1.804563492063492,2.4730534260703116,"['CEBPB', 'CEBPD', 'IL17RB']",0.7041103117938867,0,0,3
158,Wnt signaling in kidney disease WP4150,0.253994130738434,1.804563492063492,2.4730534260703116,"['WNT7B', 'FZD9', 'WNT7A']",0.7041103117938867,0,0,3
159,22q11.2 copy number variation syndrome WP4657,0.27160812832524706,1.366450163147202,1.7810242505250486,"['ACTA2', 'SREBF1', 'AIFM3', 'SERPIND1', 'HES1', 'SLC2A4', 'PRODH']",0.7385336599001732,0,0,7
160,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.2742885034426805,1.5608798355676903,2.0191148121682443,"['SMAD1', 'EGF', 'SMAD9', 'FOS']",0.7385336599001732,0,0,4
161,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.2849593345276924,3.6066176470588234,4.527779513460862,['GSTP1'],0.7385336599001732,0,0,1
162,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.2849593345276924,3.6066176470588234,4.527779513460862,['HSD11B1'],0.7385336599001732,0,0,1
163,Liver X receptor pathway WP2874,0.2849593345276924,3.6066176470588234,4.527779513460862,['SREBF1'],0.7385336599001732,0,0,1
164,miR-517 relationship with ARCN1 and USP1 WP3596,0.2849593345276924,3.6066176470588234,4.527779513460862,['CDKN1A'],0.7385336599001732,0,0,1
165,NAD Biosynthesis II (from tryptophan) WP2485,0.2849593345276924,3.6066176470588234,4.527779513460862,['HAAO'],0.7385336599001732,0,0,1
166,Osteoblast Signaling WP322,0.2849593345276924,3.6066176470588234,4.527779513460862,['TNFRSF11B'],0.7385336599001732,0,0,1
167,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.2849593345276924,3.6066176470588234,4.527779513460862,['VEGFA'],0.7385336599001732,0,0,1
168,Serotonin Transporter Activity WP1455,0.2849593345276924,3.6066176470588234,4.527779513460862,['IL1R1'],0.7385336599001732,0,0,1
169,Vitamin D Metabolism WP1531,0.2849593345276924,3.6066176470588234,4.527779513460862,['DHCR7'],0.7385336599001732,0,0,1
170,Prion disease pathway WP3995,0.2899851371323311,1.6654892726321298,2.061751821411308,"['SPI1', 'HSPA5', 'EBF1']",0.7471381768468296,0,0,3
171,Corticotropin-releasing hormone signaling pathway WP2355,0.30111500409031006,1.3537755972696246,1.6248867784080117,"['HSP90AA1', 'IL18', 'PRKCQ', 'FOS', 'JUNB', 'FOSL2']",0.7588146178525987,0,0,6
172,Angiogenesis WP1539,0.3031793564479561,1.9240468101170254,2.296216556685117,"['SMAD1', 'VEGFA']",0.7588146178525987,0,0,2
173,Apoptosis Modulation by HSP70 WP384,0.3031793564479561,1.9240468101170254,2.296216556685117,"['TNFRSF1A', 'HSPA1A']",0.7588146178525987,0,0,2
174,Monoamine Transport WP727,0.3031793564479561,1.9240468101170254,2.296216556685117,"['IL1R1', 'TNFRSF11B']",0.7588146178525987,0,0,2
175,Statin inhibition of cholesterol production WP430,0.3031793564479561,1.9240468101170254,2.296216556685117,"['APOC1', 'APOE']",0.7588146178525987,0,0,2
176,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.3276588246843828,1.803652321630804,2.012483481193119,"['UGCG', 'ST6GALNAC3']",0.7887885833033917,0,0,2
177,NAD+ biosynthetic pathways WP3645,0.3276588246843828,1.803652321630804,2.012483481193119,"['NAMPT', 'CD38']",0.7887885833033917,0,0,2
178,Urea cycle and associated pathways WP4595,0.3276588246843828,1.803652321630804,2.012483481193119,"['PYCR1', 'GPT']",0.7887885833033917,0,0,2
179,Aspirin and miRNAs WP4707,0.3313632404744842,2.8850678733031674,3.186673163244669,['VEGFA'],0.7887885833033917,0,0,1
180,Blood Clotting Cascade WP272,0.3313632404744842,2.8850678733031674,3.186673163244669,['F11'],0.7887885833033917,0,0,1
181,HIF1A and PPARG regulation of glycolysis WP2456,0.3313632404744842,2.8850678733031674,3.186673163244669,['SLC2A1'],0.7887885833033917,0,0,1
182,LDLRAD4 and what we know about it WP4904,0.3313632404744842,2.8850678733031674,3.186673163244669,['NEDD4'],0.7887885833033917,0,0,1
183,"Phase I biotransformations, non P450 WP136",0.3313632404744842,2.8850678733031674,3.186673163244669,['PON1'],0.7887885833033917,0,0,1
184,PTF1A related regulatory pathway WP4147,0.3313632404744842,2.8850678733031674,3.186673163244669,['HES1'],0.7887885833033917,0,0,1
185,Toll-like Receptor Signaling Pathway WP75,0.33618230550726874,1.3365951178451179,1.4570245971368903,"['TICAM2', 'IRF7', 'TAB2', 'FOS', 'MYD88']",0.7959343233091011,0,0,5
186,CAMKK2  Pathway WP4874,0.3444741763428707,1.4928454140276801,1.5909793258160778,"['HMOX1', 'NFATC2', 'ICAM1']",0.8069208265856856,0,0,3
187,Myometrial relaxation and contraction pathways WP289,0.3481713413248384,1.2032914764079148,1.2695453792409312,"['ACTA2', 'RYR2', 'RGS17', 'OXTR', 'GRK5', 'RGS16', 'PRKCQ', 'ADM', 'FOS']",0.8069208265856856,0,0,9
188,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3518983688395204,1.69742189061355,1.7728092683100207,"['SLC2A1', 'VEGFA']",0.8069208265856856,0,0,2
189,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3518983688395204,1.69742189061355,1.7728092683100207,"['GNA14', 'CACNA1A']",0.8069208265856856,0,0,2
190,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3518983688395204,1.69742189061355,1.7728092683100207,"['IRF7', 'MYD88']",0.8069208265856856,0,0,2
191,Allograft Rejection WP2328,0.3626009438686214,1.4429705215419502,1.4638248763955517,"['C1QB', 'VIM', 'VEGFA']",0.8069208265856856,0,0,3
192,Hepatitis C and Hepatocellular Carcinoma WP3646,0.3626009438686214,1.4429705215419502,1.4638248763955517,"['CDKN1A', 'CD44', 'VEGFA']",0.8069208265856856,0,0,3
193,VEGFA-VEGFR2 Signaling Pathway WP3888,0.36976057483413455,1.0889372543064906,1.08338321460716,"['HSPB1', 'PLA2G5', 'NDRG1', 'APOLD1', 'ICAM1', 'STIP1', 'ADAMTS1', 'DNAJB4', 'CCL2', 'SH3BGRL3', 'MYH11', 'TMSB10', 'HSP90AA1', 'ANXA1', 'SDF2L1', 'NFATC2', 'RHOC', 'SOD2', 'VEGFA', 'RCN1', 'TXNIP', 'RPL26', 'DSC1', 'ARF6', 'HSPA1A', 'EPHA2']",0.8069208265856856,0,0,26
194,Senescence and Autophagy in Cancer WP615,0.3712690740389321,1.2371526084836666,1.2258057074090982,"['CDKN1A', 'CEBPB', 'IFI16', 'IRF7', 'COL10A1', 'CD44']",0.8069208265856856,0,0,6
195,Biogenic Amine Synthesis WP550,0.37475885521174057,2.4040346907993966,2.3594939684226315,['PAH'],0.8069208265856856,0,0,1
196,Caloric restriction and aging WP4191,0.37475885521174057,2.4040346907993966,2.3594939684226315,['NAMPT'],0.8069208265856856,0,0,1
197,"Cerebral organic acidurias, including diseases WP4519",0.37475885521174057,2.4040346907993966,2.3594939684226315,['ADHFE1'],0.8069208265856856,0,0,1
198,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.37475885521174057,2.4040346907993966,2.3594939684226315,['DHCR7'],0.8069208265856856,0,0,1
199,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.37475885521174057,2.4040346907993966,2.3594939684226315,['SPI1'],0.8069208265856856,0,0,1
200,Dual hijack model of Vif in HIV infection WP3300,0.37475885521174057,2.4040346907993966,2.3594939684226315,['RUNX1'],0.8069208265856856,0,0,1
201,Estrogen metabolism WP697,0.37475885521174057,2.4040346907993966,2.3594939684226315,['NQO1'],0.8069208265856856,0,0,1
202,Ketogenesis and Ketolysis WP4742,0.37475885521174057,2.4040346907993966,2.3594939684226315,['SLC2A1'],0.8069208265856856,0,0,1
203,Nephrogenesis WP5052,0.37475885521174057,2.4040346907993966,2.3594939684226315,['RSPO3'],0.8069208265856856,0,0,1
204,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3758261384097714,1.6029948408204353,1.5687366616041634,"['CEBPB', 'ATP2C2']",0.8069208265856856,0,0,2
205,Cardiac Hypertrophic Response WP2795,0.3790777843557367,1.311835723867506,1.27249883313278,"['EGF', 'NFATC2', 'NRG1', 'TNFRSF1A']",0.809932046574696,0,0,4
206,TNF-alpha signaling pathway WP231,0.3830714831899534,1.2196317838773254,1.1702777580149768,"['HSP90AA1', 'OTUD7B', 'CCL2', 'TAB2', 'PYGL', 'TNFRSF1A']",0.8144917943553377,0,0,6
207,Cell cycle WP179,0.38832073104651044,1.1885836794854616,1.1243094176802153,"['CCNB3', 'CCNA2', 'CDKN1A', 'GADD45B', 'GADD45A', 'CDC7', 'SMC1B']",0.8216641555476888,0,0,7
208,Unfolded protein response WP4925,0.39938059409944526,1.5185074804792276,1.393747584372963,"['HSPA5', 'TXNIP']",0.8255104864227573,0,0,2
209,"GPCRs, Class A Rhodopsin-like WP455",0.4017865704354453,1.2228428351309708,1.1150299802533148,"['GPR39', 'OXTR', 'HTR1E', 'HTR2B', 'ACKR4']",0.8255104864227573,0,0,5
210,DNA damage response WP707,0.40902592530114723,1.254601983911563,1.1215849889449443,"['CCNB3', 'CDKN1A', 'GADD45B', 'GADD45A']",0.8255104864227573,0,0,4
211,Biomarkers for urea cycle disorders WP4583,0.4153409946520535,2.0604395604395602,1.8104163920609175,['GPT'],0.8255104864227573,0,0,1
212,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.4153409946520535,2.0604395604395602,1.8104163920609175,['HMOX1'],0.8255104864227573,0,0,1
213,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4153409946520535,2.0604395604395602,1.8104163920609175,['SLC2A4'],0.8255104864227573,0,0,1
214,Insulin signaling in adipocytes (normal condition) WP3634,0.4153409946520535,2.0604395604395602,1.8104163920609175,['SLC2A4'],0.8255104864227573,0,0,1
215,LTF danger signal response pathway WP4478,0.4153409946520535,2.0604395604395602,1.8104163920609175,['MYD88'],0.8255104864227573,0,0,1
216,Nanoparticle triggered regulated necrosis WP2513,0.4153409946520535,2.0604395604395602,1.8104163920609175,['TNFRSF1A'],0.8255104864227573,0,0,1
217,Osteoclast Signaling WP12,0.4153409946520535,2.0604395604395602,1.8104163920609175,['TNFRSF11B'],0.8255104864227573,0,0,1
218,RAS and bradykinin pathways in COVID-19 WP4969,0.4153409946520535,2.0604395604395602,1.8104163920609175,['SERPING1'],0.8255104864227573,0,0,1
219,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4153409946520535,2.0604395604395602,1.8104163920609175,['MYD88'],0.8255104864227573,0,0,1
220,IL-6 signaling pathway WP364,0.41636214329038046,1.3114821686250258,1.1491204934106127,"['SOCS3', 'TIMP1', 'JUNB']",0.8255104864227573,0,0,3
221,PI3K-Akt signaling pathway WP4172,0.4165246974872816,1.0880263385894993,0.9529038269193276,"['CDKN1A', 'HSP90AA1', 'LAMA2', 'BDNF', 'EGF', 'HGF', 'TNC', 'OSMR', 'VEGFA', 'THBS3', 'EFNA1', 'COL4A1', 'IL3RA', 'FGFR3', 'EPHA2']",0.8255104864227573,0,0,15
222,miRNA regulation of DNA damage response WP1530,0.4386687602543459,1.2021377222852818,0.9905743257928012,"['CCNB3', 'CDKN1A', 'GADD45B', 'GADD45A']",0.8489769895216955,0,0,4
223,Ebola Virus Pathway on Host WP4217,0.4422695881251524,1.1221083270058214,0.9154559818875222,"['BST2', 'SOCS3', 'ACTN1', 'NEDD4', 'IRF7', 'FLNA', 'RHOC']",0.8489769895216955,0,0,7
224,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.4451688559368321,1.3736720056085854,1.1117149757045632,"['P3H2', 'TNFRSF11B']",0.8489769895216955,0,0,2
225,IL-3 signaling pathway WP286,0.45138202975891883,1.2363459669582118,0.9834405509840304,"['IL3RA', 'ENPP3', 'FOS']",0.8489769895216955,0,0,3
226,Notch Signaling WP268,0.45138202975891883,1.2363459669582118,0.9834405509840304,"['LFNG', 'HES1', 'HES5']",0.8489769895216955,0,0,3
227,"Degradation pathway of sphingolipids, including diseases WP4153",0.45329187186047104,1.8027432126696832,1.426364776149971,['NEU4'],0.8489769895216955,0,0,1
228,Dopamine metabolism WP2436,0.45329187186047104,1.8027432126696832,1.426364776149971,['NQO1'],0.8489769895216955,0,0,1
229,Estrogen Receptor Pathway WP2881,0.45329187186047104,1.8027432126696832,1.426364776149971,['PDK4'],0.8489769895216955,0,0,1
230,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.45329187186047104,1.8027432126696832,1.426364776149971,['CEBPB'],0.8489769895216955,0,0,1
231,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.45329187186047104,1.8027432126696832,1.426364776149971,['BHMT'],0.8489769895216955,0,0,1
232,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.45329187186047104,1.8027432126696832,1.426364776149971,['PRKCQ'],0.8489769895216955,0,0,1
233,NLR Proteins WP288,0.45329187186047104,1.8027432126696832,1.426364776149971,['ERBIN'],0.8489769895216955,0,0,1
234,Regulation of toll-like receptor signaling pathway WP1449,0.4535630491965223,1.1240636496609193,0.8887083167473182,"['TICAM2', 'IRAK2', 'IRF7', 'TAB2', 'FOS', 'MYD88']",0.8489769895216955,0,0,6
235,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4673222880712003,1.3111294141871719,0.9974235230205539,"['HSPB1', 'NDRG1']",0.8623215837655784,0,0,2
236,MTHFR deficiency WP4288,0.4673222880712003,1.3111294141871719,0.9974235230205539,"['BHMT', 'GRIN2D']",0.8623215837655784,0,0,2
237,Glycogen Synthesis and Degradation WP500,0.4685674359274148,1.2019085411942554,0.9111371149369704,"['HKDC1', 'PYGM', 'PYGL']",0.8623215837655784,0,0,3
238,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.4685674359274148,1.2019085411942554,0.9111371149369704,"['NFATC2', 'PRKCQ', 'FOS']",0.8623215837655784,0,0,3
239,Calcium Regulation in the Cardiac Cell WP536,0.4720609811536797,1.078442864906915,0.8095300137841825,"['RYR2', 'RGS17', 'PLN', 'GRK5', 'RGS16', 'ATP1A4', 'CACNA1A', 'PRKCQ']",0.8651159403569528,0,0,8
240,15q13.3 copy number variation syndrome WP4942,0.48878191178178426,1.6023127199597789,1.1469977383246182,['CHRNA7'],0.8667468719045406,0,0,1
241,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.48878191178178426,1.6023127199597789,1.1469977383246182,['SMAD1'],0.8667468719045406,0,0,1
242,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.48878191178178426,1.6023127199597789,1.1469977383246182,['PRKCQ'],0.8667468719045406,0,0,1
243,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.48878191178178426,1.6023127199597789,1.1469977383246182,['GRM8'],0.8667468719045406,0,0,1
244,Iron metabolism in placenta WP2007,0.48878191178178426,1.6023127199597789,1.1469977383246182,['FTH1'],0.8667468719045406,0,0,1
245,miRNAs involved in DNA damage response WP1545,0.48878191178178426,1.6023127199597789,1.1469977383246182,['CDKN1A'],0.8667468719045406,0,0,1
246,Neuroinflammation WP4919,0.48878191178178426,1.6023127199597789,1.1469977383246182,['FOS'],0.8667468719045406,0,0,1
247,Trans-sulfuration pathway WP2333,0.48878191178178426,1.6023127199597789,1.1469977383246182,['GCLM'],0.8667468719045406,0,0,1
248,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5021824310720894,1.1384711779448622,0.7841696310278317,"['SREBF1', 'MSMO1', 'DHCR7']",0.8793195560261787,0,0,3
249,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5099982614880288,1.201679879199698,0.8091486977756124,"['SLC2A1', 'VEGFA']",0.8793195560261787,0,0,2
250,AMP-activated protein kinase (AMPK) signaling WP1403,0.5105565798861242,1.08830017347354,0.7316139437273868,"['CCNA2', 'SREBF1', 'CDKN1A', 'SLC2A4']",0.8793195560261787,0,0,4
251,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5168686867928977,1.0602439839572193,0.6997254343326789,"['EGF', 'HGF', 'NRG1', 'FGFR3', 'VEGFA']",0.8793195560261787,0,0,5
252,Cytosolic DNA-sensing pathway WP4655,0.5185759174713681,1.1091923949066806,0.7283720883305393,"['RNF125', 'IL18', 'IRF7']",0.8793195560261787,0,0,3
253,Phosphodiesterases in neuronal function WP4222,0.5185759174713681,1.1091923949066806,0.7283720883305393,"['CHRNA7', 'PDE6C', 'GRIN2D']",0.8793195560261787,0,0,3
254,Alanine and aspartate metabolism WP106,0.5219705127096038,1.4419683257918552,0.9374873172916403,['GPT'],0.8793195560261787,0,0,1
255,GDNF/RET signaling axis WP4830,0.5219705127096038,1.4419683257918552,0.9374873172916403,['IFT27'],0.8793195560261787,0,0,1
256,"GPCRs, Class B Secretin-like WP334",0.5219705127096038,1.4419683257918552,0.9374873172916403,['ADGRG2'],0.8793195560261787,0,0,1
257,GPR40 Pathway WP3958,0.5219705127096038,1.4419683257918552,0.9374873172916403,['PLCE1'],0.8793195560261787,0,0,1
258,Mammalian disorder of sexual development WP4842,0.5219705127096038,1.4419683257918552,0.9374873172916403,['SOX9'],0.8793195560261787,0,0,1
259,"NAD metabolism, sirtuins and aging WP3630",0.5219705127096038,1.4419683257918552,0.9374873172916403,['NAMPT'],0.8793195560261787,0,0,1
260,RalA downstream regulated genes WP2290,0.5219705127096038,1.4419683257918552,0.9374873172916403,['YBX3'],0.8793195560261787,0,0,1
261,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.524440325113341,1.0680623870181192,0.6893527054872122,"['SFRP2', 'WNT7B', 'FZD9', 'WNT7A']",0.8800952582361815,0,0,4
262,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.550367267238397,1.1090687342102972,0.6623019826476463,"['FOS', 'MYD88']",0.9071796270611113,0,0,2
263,Trans-sulfuration and one-carbon metabolism WP2525,0.550367267238397,1.1090687342102972,0.6623019826476463,"['BHMT', 'GCLM']",0.9071796270611113,0,0,2
264,Melanoma WP4685,0.5516211574100162,1.0297551483703584,0.6125949299727581,"['CDKN1A', 'GADD45B', 'GADD45A', 'FOS']",0.9071796270611113,0,0,4
265,BMP Signaling Pathway in Eyelid Development WP3927,0.5530067589619103,1.3107774578362814,0.7764849766893425,['SMAD1'],0.9071796270611113,0,0,1
266,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5530067589619103,1.3107774578362814,0.7764849766893425,['CCL2'],0.9071796270611113,0,0,1
267,Serotonin and anxiety WP3947,0.5530067589619103,1.3107774578362814,0.7764849766893425,['FOS'],0.9071796270611113,0,0,1
268,T-cell receptor (TCR) signaling pathway WP69,0.5648994278830168,1.0116096142740507,0.5777379059939365,"['NFATC2', 'PRKCQ', 'FOS', 'VIM']",0.9073624269620431,0,0,4
269,Small cell lung cancer WP4658,0.5650294867307277,1.0010258838383839,0.5714630141511712,"['CDKN1A', 'LAMA2', 'GADD45B', 'COL4A1', 'GADD45A']",0.9073624269620431,0,0,5
270,Gastrin signaling pathway WP4659,0.5657413551060012,0.9940763406692558,0.5662440503891858,"['CDKN1A', 'ANXA2', 'PRKCQ', 'FOS', 'CD44', 'VEGFA']",0.9073624269620431,0,0,6
271,Alpha 6 Beta 4 signaling pathway WP244,0.5696548199978102,1.067908225326119,0.6009383149445424,"['LAMA2', 'IRS2']",0.9073624269620431,0,0,2
272,Development of ureteric collection system WP5053,0.5696548199978102,1.067908225326119,0.6009383149445424,"['SMAD1', 'FREM1']",0.9073624269620431,0,0,2
273,Neovascularisation processes WP4331,0.5696548199978102,1.067908225326119,0.6009383149445424,"['SMAD1', 'SMAD9']",0.9073624269620431,0,0,2
274,Proximal tubule transport WP4917,0.5696548199978102,1.067908225326119,0.6009383149445424,"['SLC22A6', 'SLC2A1']",0.9073624269620431,0,0,2
275,Pancreatic adenocarcinoma pathway WP4263,0.5766838550343388,0.9872353673723536,0.5434346407969087,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'VEGFA']",0.9073624269620431,0,0,5
276,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5820300876780233,1.2014517345399698,0.6502654894918494,['SYTL4'],0.9073624269620431,0,0,1
277,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5820300876780233,1.2014517345399698,0.6502654894918494,['ALOX12'],0.9073624269620431,0,0,1
278,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.5820300876780233,1.2014517345399698,0.6502654894918494,['SOX9'],0.9073624269620431,0,0,1
279,Omega-3/Omega-6 FA synthesis WP4723,0.5820300876780233,1.2014517345399698,0.6502654894918494,['PLA2G5'],0.9073624269620431,0,0,1
280,PPAR-alpha pathway WP2878,0.5820300876780233,1.2014517345399698,0.6502654894918494,['DBI'],0.9073624269620431,0,0,1
281,Circadian rhythm related genes WP3594,0.5865460953886033,0.9678235534655489,0.5163377563897047,"['CST3', 'SREBF1', 'NFIL3', 'KCNH7', 'NAMPT', 'UBC', 'GHRL', 'CARTPT', 'RPS27A']",0.9073624269620431,0,0,9
282,ATM Signaling Pathway WP2516,0.5883354549251604,1.0296877527908106,0.5462060979221393,"['CDKN1A', 'GADD45A']",0.9073624269620431,0,0,2
283,"GPCRs, Other WP117",0.5883354549251604,1.0296877527908106,0.5462060979221393,"['GRM8', 'GNRHR']",0.9073624269620431,0,0,2
284,Neural Crest Cell Migration during Development WP4564,0.5883354549251604,1.0296877527908106,0.5462060979221393,"['BDNF', 'FOS']",0.9073624269620431,0,0,2
285,Prolactin Signaling Pathway WP2037,0.5907914875716305,0.977163854633602,0.5142736529970063,"['SOCS3', 'FLNA', 'IRS2', 'FOS']",0.9079532335311373,0,0,4
286,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6033918068071025,0.9608021188043889,0.48538621071790955,"['CDKN1A', 'GADD45B', 'GADD45A', 'FOS']",0.9200581366640787,0,0,4
287,Focal Adhesion WP306,0.6034419372207037,0.953439766317486,0.48158762521362564,"['LAMA2', 'COL4A1', 'EGF', 'ACTN1', 'HGF', 'TNC', 'FLNA', 'VEGFA', 'THBS3']",0.9200581366640787,0,0,9
288,Vitamin D-sensitive calcium signaling in depression WP4698,0.6064066642678891,0.9941031749131097,0.49725483664888726,"['PVALB', 'GRIN2D']",0.9200581366640787,0,0,2
289,Airway smooth muscle cell contraction WP4962,0.6091709124031571,1.1089453532892446,0.5496558686003493,['CD38'],0.9200581366640787,0,0,1
290,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6091709124031571,1.1089453532892446,0.5496558686003493,['NQO1'],0.9200581366640787,0,0,1
291,Non-small cell lung cancer WP4255,0.6157540416167672,0.9449768333302321,0.4582265222719336,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.9268050523303918,0,0,4
292,Amyotrophic lateral sclerosis (ALS) WP2447,0.6238688163252049,0.9608909022272556,0.4533628976233006,"['CST3', 'TNFRSF1A']",0.9290830235053353,0,0,2
293,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6238688163252049,0.9608909022272556,0.4533628976233006,"['TSPO', 'GRIN2D']",0.9290830235053353,0,0,2
294,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6238688163252049,0.9608909022272556,0.4533628976233006,"['HGF', 'FOS']",0.9290830235053353,0,0,2
295,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6278734588072585,0.9296620409358867,0.43268017555562677,"['SFRP2', 'WNT7B', 'FZD9', 'WNT7A']",0.9290830235053353,0,0,4
296,Retinoblastoma gene in cancer WP2446,0.6278734588072585,0.9296620409358867,0.43268017555562677,"['CCNA2', 'CDKN1A', 'RBP1', 'CDC7']",0.9290830235053353,0,0,4
297,Constitutive Androstane Receptor Pathway WP2875,0.6345512062535648,1.0296541693600516,0.46832511385009806,['HSP90AA1'],0.9314058108518596,0,0,1
298,MAPK pathway in congenital thyroid cancer WP4928,0.6345512062535648,1.0296541693600516,0.46832511385009806,['FOS'],0.9314058108518596,0,0,1
299,Disruption of postsynaptic signaling by CNV WP4875,0.6407247939513663,0.9298213568114565,0.41391486120890486,"['RYR2', 'GRIN2D']",0.9314058108518596,0,0,2
300,Neural Crest Cell Migration in Cancer WP4565,0.6407247939513663,0.9298213568114565,0.41391486120890486,"['BDNF', 'FOS']",0.9314058108518596,0,0,2
301,Alzheimer's disease WP2059,0.6513685598185666,0.9004682179341658,0.38601240307381013,"['PSENEN', 'APOE', 'TNFRSF1A', 'GRIN2D']",0.9314058108518596,0,0,4
302,DNA Replication WP466,0.656979667193456,0.9006936579841449,0.3783833952898136,"['UBC', 'CDC7']",0.9314058108518596,0,0,2
303,IL-2 signaling pathway WP49,0.656979667193456,0.9006936579841449,0.3783833952898136,"['SOCS3', 'FOS']",0.9314058108518596,0,0,2
304,Prader-Willi and Angelman Syndrome WP3998,0.656979667193456,0.9006936579841449,0.3783833952898136,"['BDNF', 'GHRL']",0.9314058108518596,0,0,2
305,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6582850477142926,0.9609351432880845,0.4017835482480507,['PLA2G5'],0.9314058108518596,0,0,1
306,miRNA targets in ECM and membrane receptors WP2911,0.6582850477142926,0.9609351432880845,0.4017835482480507,['COL4A1'],0.9314058108518596,0,0,1
307,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6582850477142926,0.9609351432880845,0.4017835482480507,['BCL2L14'],0.9314058108518596,0,0,1
308,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6582850477142926,0.9609351432880845,0.4017835482480507,['SREBF1'],0.9314058108518596,0,0,1
309,Triacylglyceride synthesis WP325,0.6582850477142926,0.9609351432880845,0.4017835482480507,['MOGAT1'],0.9314058108518596,0,0,1
310,DNA damage response (only ATM dependent) WP710,0.6635148638286379,0.8891694725028059,0.3647408950229606,"['CDKN1A', 'BCL6', 'WNT7B', 'WNT7A', 'SOD2']",0.9314058108518596,0,0,5
311,Wnt signaling WP428,0.6635148638286379,0.8891694725028059,0.3647408950229606,"['SFRP2', 'WNT7B', 'FZD9', 'NFATC2', 'WNT7A']",0.9314058108518596,0,0,5
312,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6726403980272643,0.8733312742372765,0.34631464273246576,"['HSPB1', 'LMNB1']",0.9314058108518596,0,0,2
313,Amino Acid metabolism WP3925,0.6738533562751551,0.8730437175386097,0.34462769018385764,"['BHMT', 'PDK4', 'PYCR1', 'GCLM']",0.9314058108518596,0,0,4
314,Hepatitis B infection WP4666,0.676838562664377,0.8841965391839508,0.345121798697597,"['CDKN1A', 'TICAM2', 'IRF7', 'NFATC2', 'TAB2', 'FOS', 'MYD88']",0.9314058108518596,0,0,7
315,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.677261285993896,0.864421768707483,0.33686355000616947,"['CDKN1A', 'PLCE1', 'VIM']",0.9314058108518596,0,0,3
316,Gastric Cancer Network 1 WP2361,0.6804791312159705,0.9008059954751131,0.34677258628620033,['GATD3A'],0.9314058108518596,0,0,1
317,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6804791312159705,0.9008059954751131,0.34677258628620033,['FLNA'],0.9314058108518596,0,0,1
318,Microglia Pathogen Phagocytosis Pathway WP3937,0.6804791312159705,0.9008059954751131,0.34677258628620033,['C1QB'],0.9314058108518596,0,0,1
319,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6804791312159705,0.9008059954751131,0.34677258628620033,['SOX9'],0.9314058108518596,0,0,1
320,Urea cycle and metabolism of amino groups WP497,0.6804791312159705,0.9008059954751131,0.34677258628620033,['PYCR1'],0.9314058108518596,0,0,1
321,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6895786897583125,0.847405628918234,0.31495903159069055,"['SOCS3', 'IL3RA', 'OSMR']",0.9409204551842394,0,0,3
322,Ebstein-Barr virus LMP1 signaling WP262,0.7012332442859734,0.8477508650519031,0.30087925793002235,['HSP90AA1'],0.9507247980123593,0,0,1
323,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7012332442859734,0.8477508650519031,0.30087925793002235,['HTR2B'],0.9507247980123593,0,0,1
324,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.709691869960016,0.846884829016931,0.29041746264372237,"['CLDN20', 'COL4A1', 'MMP15', 'WNT7B', 'FZD9', 'WNT7A']",0.9507247980123593,0,0,6
325,Insulin Signaling WP481,0.7172250082639052,0.8528738544702057,0.2834659888352356,"['SOCS3', 'SLC2A1', 'IRS2', 'PRKCQ', 'SLC2A4', 'FOS', 'MAP3K6', 'ARF6']",0.9507247980123593,0,0,8
326,Cardiac Progenitor Differentiation WP2406,0.7206407144751217,0.8005907491201609,0.26228520319866433,['NRG1'],0.9507247980123593,0,0,1
327,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7206407144751217,0.8005907491201609,0.26228520319866433,['BCL6'],0.9507247980123593,0,0,1
328,Genes controlling nephrogenesis WP4823,0.7206407144751217,0.8005907491201609,0.26228520319866433,['VEGFA'],0.9507247980123593,0,0,1
329,Hippo-Yap signaling pathway WP4537,0.7206407144751217,0.8005907491201609,0.26228520319866433,['NDRG1'],0.9507247980123593,0,0,1
330,Kallmann's Syndrome WP5074,0.7206407144751217,0.8005907491201609,0.26228520319866433,['PRKCQ'],0.9507247980123593,0,0,1
331,Methionine De Novo and Salvage Pathway WP3580,0.7206407144751217,0.8005907491201609,0.26228520319866433,['BHMT'],0.9507247980123593,0,0,1
332,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7206407144751217,0.8005907491201609,0.26228520319866433,['NFATC2'],0.9507247980123593,0,0,1
333,Metabolic reprogramming in colon cancer WP4290,0.7295331719205063,0.7786722169508127,0.2455546261695682,"['SLC2A1', 'PYCR1']",0.9545413161632286,0,0,2
334,Netrin-UNC5B signaling pathway WP4747,0.7295331719205063,0.7786722169508127,0.2455546261695682,"['CCL2', 'ICAM1']",0.9545413161632286,0,0,2
335,Canonical and non-canonical Notch signaling WP3845,0.7387888268934577,0.7583948559180758,0.22959885072500516,['HES1'],0.9545413161632286,0,0,1
336,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7387888268934577,0.7583948559180758,0.22959885072500516,['BDNF'],0.9545413161632286,0,0,1
337,Glycerolipids and Glycerophospholipids WP4722,0.7387888268934577,0.7583948559180758,0.22959885072500516,['PNPLA3'],0.9545413161632286,0,0,1
338,Immune response to tuberculosis WP4197,0.7387888268934577,0.7583948559180758,0.22959885072500516,['TAP1'],0.9545413161632286,0,0,1
339,Signal Transduction of S1P Receptor WP26,0.7387888268934577,0.7583948559180758,0.22959885072500516,['S1PR3'],0.9545413161632286,0,0,1
340,Interleukin-11 Signaling Pathway WP2332,0.7423766241562512,0.7581212374083567,0.22584324377957124,"['SOCS3', 'ICAM1']",0.9563557687659943,0,0,2
341,EPO Receptor Signaling WP581,0.7557592151314207,0.7204185520361991,0.20174057361995623,['IRS2'],0.9628865051494266,0,0,1
342,SARS-CoV-2 mitochondrial interactions WP5038,0.7557592151314207,0.7204185520361991,0.20174057361995623,['IRF7'],0.9628865051494266,0,0,1
343,Sphingolipid Metabolism (general overview) WP4725,0.7557592151314207,0.7204185520361991,0.20174057361995623,['UGCG'],0.9628865051494266,0,0,1
344,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7571453088912931,0.7994564530400707,0.22240885746197608,"['SREBF1', 'SLC2A1', 'TRIP10', 'IRS2', 'SLC2A4', 'MAP3K6']",0.9628865051494266,0,0,6
345,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7665001594142704,0.7201019252548131,0.1914897723410095,"['BANF1', 'SYNE2']",0.9628865051494266,0,0,2
346,Pathogenic Escherichia coli infection WP2272,0.7665001594142704,0.7201019252548131,0.1914897723410095,"['TUBB2B', 'TUBA1A']",0.9628865051494266,0,0,2
347,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7716282267293351,0.6860590390002155,0.17786246375288475,['SREBF1'],0.9628865051494266,0,0,1
348,Estrogen signaling pathway WP712,0.7716282267293351,0.6860590390002155,0.17786246375288475,['FOS'],0.9628865051494266,0,0,1
349,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7716282267293351,0.6860590390002155,0.17786246375288475,['HGF'],0.9628865051494266,0,0,1
350,Fluoropyrimidine Activity WP1601,0.7716282267293351,0.6860590390002155,0.17786246375288475,['XRCC3'],0.9628865051494266,0,0,1
351,Sphingolipid Metabolism (integrated pathway) WP4726,0.7716282267293351,0.6860590390002155,0.17786246375288475,['UGCG'],0.9628865051494266,0,0,1
352,Head and Neck Squamous Cell Carcinoma WP4674,0.7755445871833023,0.7320419693301049,0.18607760416374575,"['CDKN1A', 'FGFR3', 'VEGFA']",0.9650242306428591,0,0,3
353,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7778087967707316,0.7024832196226832,0.1765161531467168,"['HSPA5', 'PPP1R3C']",0.9650998668146754,0,0,2
354,Photodynamic therapy-induced unfolded protein response WP3613,0.7864672652315848,0.6548231180584122,0.15729124891449703,['HSPA5'],0.9675688926919739,0,0,1
355,Physiological and pathological hypertrophy of the heart WP1528,0.7864672652315848,0.6548231180584122,0.15729124891449703,['FOS'],0.9675688926919739,0,0,1
356,Pre-implantation embryo WP3527,0.7864672652315848,0.6548231180584122,0.15729124891449703,['ZFP36'],0.9675688926919739,0,0,1
357,Synaptic Vesicle Pathway WP2267,0.7886349193859239,0.6857034999730357,0.16282151545055806,"['CACNA1A', 'SYN3']",0.9675688926919739,0,0,2
358,ErbB signaling pathway WP673,0.7951999422914819,0.7286311584936566,0.1669743521924826,"['CDKN1A', 'NRG4', 'EGF', 'NRG1']",0.968370945089719,0,0,4
359,Phosphoinositides metabolism WP4971,0.798993456976085,0.6697042324001159,0.1502833189225044,"['MTMR11', 'PLCE1']",0.968370945089719,0,0,2
360,Gastric Cancer Network 2 WP2363,0.800343109868672,0.6263033641550265,0.13948700088232624,['S100A6'],0.968370945089719,0,0,1
361,Sphingolipid pathway WP1422,0.800343109868672,0.6263033641550265,0.13948700088232624,['UGCG'],0.968370945089719,0,0,1
362,Tryptophan metabolism WP465,0.800343109868672,0.6263033641550265,0.13948700088232624,['HAAO'],0.968370945089719,0,0,1
363,G1 to S cell cycle control WP45,0.8088994345159046,0.6544322042623288,0.1387924256087793,"['CDKN1A', 'GADD45A']",0.9719749457349668,0,0,2
364,Glycosylation and related congenital defects WP4521,0.8133182147538989,0.6001602564102564,0.1240128170087135,['MGAT2'],0.9719749457349668,0,0,1
365,Resistin as a regulator of inflammation WP4481,0.8133182147538989,0.6001602564102564,0.1240128170087135,['PLCE1'],0.9719749457349668,0,0,1
366,Interferon type I signaling pathways WP585,0.8183678977965627,0.6398389329306656,0.128251421222017,"['SOCS3', 'IRS2']",0.9719749457349668,0,0,2
367,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8183678977965627,0.6398389329306656,0.128251421222017,"['RNF125', 'IRF7']",0.9719749457349668,0,0,2
368,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8183678977965627,0.6398389329306656,0.128251421222017,"['BDNF', 'GRIN2D']",0.9719749457349668,0,0,2
369,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8254509887242344,0.5761085972850679,0.11051225578546757,['PRKCQ'],0.9719749457349668,0,0,1
370,One-carbon metabolism WP241,0.8254509887242344,0.5761085972850679,0.11051225578546757,['BHMT'],0.9719749457349668,0,0,1
371,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8254509887242344,0.5761085972850679,0.11051225578546757,['NDRG1'],0.9719749457349668,0,0,1
372,Rett syndrome causing genes WP4312,0.8274138468805997,0.6258801516569009,0.11857317603761533,"['HAP1', 'SYNE2']",0.9719749457349668,0,0,2
373,EGF/EGFR signaling pathway WP437,0.8277320884911933,0.7398750502478896,0.13988502505118908,"['PTPRR', 'PLSCR1', 'EGF', 'NEDD4', 'PLCE1', 'FOS', 'ARF6']",0.9719749457349668,0,0,7
374,Intraflagellar transport proteins binding to dynein WP4532,0.8367960571646867,0.5539070657848938,0.0986923346618101,['IFT27'],0.9746825862797116,0,0,1
375,Lipid Metabolism Pathway WP3965,0.8367960571646867,0.5539070657848938,0.0986923346618101,['HILPDA'],0.9746825862797116,0,0,1
376,Melatonin metabolism and effects WP3298,0.8367960571646867,0.5539070657848938,0.0986923346618101,['APOE'],0.9746825862797116,0,0,1
377,TGF-beta Signaling Pathway WP366,0.8434866294174158,0.6912696678321678,0.1176618593414494,"['CDKN1A', 'KLF6', 'TNC', 'FOS', 'JUNB']",0.9746825862797116,0,0,5
378,Kit receptor signaling pathway WP304,0.8442976402322713,0.599707436768592,0.10150059896711149,"['FOS', 'JUNB']",0.9746825862797116,0,0,2
379,BDNF-TrkB Signaling WP3676,0.847404506654194,0.5333500921736216,0.08831057359534351,['BDNF'],0.9746825862797116,0,0,1
380,Nuclear receptors WP170,0.847404506654194,0.5333500921736216,0.08831057359534351,['ESRRB'],0.9746825862797116,0,0,1
381,B Cell Receptor Signaling Pathway WP23,0.8478403319008451,0.634703881552621,0.10476609428572531,"['BCL6', 'CD81', 'NFATC2']",0.9746825862797116,0,0,3
382,Nonalcoholic fatty liver disease WP4396,0.8553762593499753,0.6954200154134097,0.1086342292349909,"['SOCS3', 'SREBF1', 'CCL2', 'IRS2', 'COX7A1', 'TNFRSF1A']",0.9804385429813813,0,0,6
383,PDGFR-beta pathway WP3972,0.8573241140681942,0.5142614738202973,0.07916501826597146,['FOS'],0.9804385429813813,0,0,1
384,miRNA regulation of prostate cancer signaling pathways WP3981,0.8665995608434718,0.4964893119051334,0.07108648394673227,['CDKN1A'],0.9808226514505157,0,0,1
385,AGE/RAGE pathway WP2324,0.8668210968098499,0.5642972930961739,0.08065087630396563,"['LGALS3', 'MYD88']",0.9808226514505157,0,0,2
386,Pathways in clear cell renal cell carcinoma WP4018,0.8669806825351302,0.6077416882245856,0.08674818756692869,"['SLC2A1', 'ENPP3', 'VEGFA']",0.9808226514505157,0,0,3
387,Pathways Regulating Hippo Signaling WP4540,0.8669806825351302,0.6077416882245856,0.08674818756692869,"['PRKCQ', 'FGFR3', 'EPHA2']",0.9808226514505157,0,0,3
388,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8736380951533402,0.5534018642738915,0.07475854199276823,"['CDKN1A', 'FZD9']",0.9808226514505157,0,0,2
389,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8752726331829974,0.47990196078431374,0.06393247220945414,['NFATC2'],0.9808226514505157,0,0,1
390,MET in type 1 papillary renal cell carcinoma WP4205,0.8801323620385889,0.5429175837090536,0.06932133032037022,"['CDKN1A', 'HGF']",0.9808226514505157,0,0,2
391,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8833824095884301,0.4643847613487082,0.05758236006395115,['TNFRSF1A'],0.9808226514505157,0,0,1
392,IL-5 signaling pathway WP127,0.8833824095884301,0.4643847613487082,0.05758236006395115,['FOS'],0.9808226514505157,0,0,1
393,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8833824095884301,0.4643847613487082,0.05758236006395115,['BDNF'],0.9808226514505157,0,0,1
394,p38 MAPK Signaling Pathway WP400,0.8833824095884301,0.4643847613487082,0.05758236006395115,['HSPB1'],0.9808226514505157,0,0,1
395,Androgen receptor signaling pathway WP138,0.8941897390224727,0.5675349087003222,0.06347156633088892,"['CDKN1A', 'PRDX1', 'FLNA']",0.9808226514505157,0,0,3
396,Target Of Rapamycin (TOR) Signaling WP1471,0.8980558898623537,0.4361716714657891,0.046898475492317855,['DDIT4L'],0.9808226514505157,0,0,1
397,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8980558898623537,0.4361716714657891,0.046898475492317855,['CCL2'],0.9808226514505157,0,0,1
398,Hippo-Merlin Signaling Dysregulation WP4541,0.8989917658362986,0.5601201519568867,0.059642380077141795,"['FGFR3', 'CD44', 'EPHA2']",0.9808226514505157,0,0,3
399,Apoptosis WP254,0.9031394236041782,0.504659156384733,0.05141383562250714,"['IRF7', 'TNFRSF1A']",0.9808226514505157,0,0,2
400,Proteasome Degradation WP183,0.9031394236041782,0.504659156384733,0.05141383562250714,"['NEDD4', 'UBC']",0.9808226514505157,0,0,2
401,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9031394236041782,0.504659156384733,0.05141383562250714,"['PAX8', 'FOS']",0.9808226514505157,0,0,2
402,Integrated Cancer Pathway WP1971,0.9046857333013889,0.42330982166622305,0.04240195073979976,['CDKN1A'],0.9808226514505157,0,0,1
403,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9046857333013889,0.42330982166622305,0.04240195073979976,['ACTA2'],0.9808226514505157,0,0,1
404,Nephrotic syndrome WP4758,0.9046857333013889,0.42330982166622305,0.04240195073979976,['PLCE1'],0.9808226514505157,0,0,1
405,PDGF Pathway WP2526,0.9108848569655865,0.41118293471234646,0.03837931415110137,['FOS'],0.9841549518926045,0,0,1
406,Mesodermal commitment pathway WP2857,0.9122532202474828,0.5746651532349603,0.05277591081021438,"['SMAD1', 'TRIM5', 'HMGA2', 'TBX6']",0.9841549518926045,0,0,4
407,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9300366332639307,0.4563806647611857,0.033101884281073635,"['SREBF1', 'DBI']",0.9945000592031701,0,0,2
408,16p11.2 proximal deletion syndrome WP4949,0.9337683822207731,0.4492143261608154,0.030783245568159624,"['TBX6', 'CCT6B']",0.9945000592031701,0,0,2
409,7q11.23 copy number variation syndrome WP4932,0.9341108941016701,0.5011469704160734,0.03415823638813053,"['FZD9', 'NRG1', 'ATP5F1E']",0.9945000592031701,0,0,3
410,ATM Signaling Network in Development and Disease  WP3878,0.9363370116548886,0.35964366515837104,0.02365729272498946,['HSPB1'],0.9945000592031701,0,0,1
411,Modulators of TCR signaling and T cell activation WP5072,0.9363370116548886,0.35964366515837104,0.02365729272498946,['PRKCQ'],0.9945000592031701,0,0,1
412,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9404793510519273,0.350844277673546,0.021529764613406582,['PIM1'],0.9945000592031701,0,0,1
413,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9438641867386116,0.4289988336911141,0.024784546687573086,"['PAX8', 'PRKCQ']",0.9945000592031701,0,0,2
414,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9443524368693046,0.34246390864037923,0.019608058201016628,['CP'],0.9945000592031701,0,0,1
415,Glioblastoma signaling pathways WP2261,0.9468911286264271,0.4226567184065019,0.023064866093568268,"['CDKN1A', 'PRKCQ']",0.9945000592031701,0,0,2
416,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9468911286264271,0.4226567184065019,0.023064866093568268,"['EGF', 'NRG1']",0.9945000592031701,0,0,2
417,Joubert Syndrome WP4656,0.949762150024704,0.4164984325504292,0.021467867813002906,"['NEK8', 'FLNA']",0.9945000592031701,0,0,2
418,Ectoderm Differentiation WP2858,0.9504281433643351,0.5080308981145721,0.025829672036845153,"['PIM1', 'HESX1', 'CCL2', 'TNFRSF11B']",0.9945000592031701,0,0,4
419,Wnt Signaling Pathway WP363,0.951359645676092,0.3268459481694776,0.016297555993449703,['NFATC2'],0.9945000592031701,0,0,1
420,Pyrimidine metabolism WP4022,0.9575127658790575,0.39904995595822323,0.017325242875821344,"['ENTPD3', 'ENPP3']",0.9962541767826872,0,0,2
421,Ras signaling WP4223,0.9575867772271949,0.5233908427339085,0.022683200705828778,"['PLCE1', 'PLA2G5', 'FGFR3', 'EPHA2', 'ARF6']",0.9962541767826872,0,0,5
422,Oxidative phosphorylation WP623,0.9652594946265388,0.29337889001754547,0.010373380990596323,['ATP5F1E'],0.9990357252335085,0,0,1
423,G Protein Signaling Pathways WP35,0.9679496379751787,0.37299054286596756,0.012150248970947285,"['GNA14', 'PRKCQ']",0.9990357252335085,0,0,2
424,Acute viral myocarditis WP4298,0.9716133126362421,0.2763879220327184,0.007959248068373058,['LAMA2'],0.9990357252335085,0,0,1
425,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9734618814920266,0.27115171177324343,0.0072930621358764025,['ANGPTL1'],0.9990357252335085,0,0,1
426,3q29 copy number variation syndrome WP4906,0.9751901859404436,0.2661094352270823,0.0066854046733659704,['SLC51A'],0.9990357252335085,0,0,1
427,Pathways affected in adenoid cystic carcinoma WP3651,0.9768060419941021,0.26125051419169065,0.0061308104138605,['ERBIN'],0.9990357252335085,0,0,1
428,Ciliopathies WP4803,0.9769386897716418,0.47433774834437087,0.011066955425957458,"['NEK8', 'DNAH11', 'DNAH6', 'IFT27', 'PKD1L1']",0.9990357252335085,0,0,5
429,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9785075938930938,0.34171924715526075,0.007424442306351278,"['COX7A1', 'ATP5F1E']",0.9990357252335085,0,0,2
430,Ciliary landscape WP4352,0.9811648581174097,0.5083079911658939,0.009665365868443318,"['NEK8', 'WHRN', 'CDH23', 'USH1C', 'IFT27', 'VIM', 'MAPRE2']",0.9994190880358731,0,0,7
431,Regulation of Actin Cytoskeleton WP51,0.9848103831453838,0.3739130434782609,0.005723173154611326,"['EGF', 'ACTN1', 'FGFR3']",0.9995932828800905,0,0,3
432,DNA IR-damage and cellular response via ATR WP4016,0.9881755413510019,0.22088409328228334,0.0026273994105439178,['BCL6'],0.9995932828800905,0,0,1
433,Leptin signaling pathway WP2034,0.98894619765614,0.21752022487316605,0.002417813342650606,['SOCS3'],0.9995932828800905,0,0,1
434,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9919771262650948,0.3382612887674755,0.002724772536464035,"['BDNF', 'IRS2', 'FOS']",0.9995932828800905,0,0,3
435,Endoderm differentiation WP2853,0.9987225597591787,0.14612383414904423,0.00018678379386895483,['TRIM5'],0.9995932828800905,0,0,1
436,Genes related to primary cilium development (based on CRISPR) WP4536,0.9988058465101302,0.1446364093422917,0.00017282128109554986,['IFT27'],0.9995932828800905,0,0,1
437,Chemokine signaling pathway WP3929,0.9990880503039296,0.13897553046610728,0.00012679651758419242,['GRK5'],0.9995932828800905,0,0,1
438,Fragile X Syndrome  WP4549,0.9995932828800905,0.1243556954554397,5.058787847558458e-05,['BDNF'],0.9995932828800905,0,0,1
